The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca
|
|
- Erin Woods
- 8 years ago
- Views:
Transcription
1
2 The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings Prof. Tony Pagliuca
3 UK STEM CELL STRATEGIC FORUM The future of unrelated donor SCT in the UK Antonio Pagliuca, Transplant Director King s College Hospital, London EBMT (UK) NAP GROUP 40 TH MEETING 30 th June 2011
4 Background The UK Stem Cell Strategic Forum was set up at the request of the Minister of State for Public Health in January 2010 To advise on future options for the provision and use of stem cells derived from unrelated adult volunteer donors and cord blood Also to be seen in the context of London Cancer Services: a proposed model of Care, commissioning models July 2010 Harmonisation of processes and costs The report, July 2010, was the result of three months of intensive effort by over forty scientists, clinicians, economists, and patient representatives
5 UK STEM CELL STRATEGIC FORUM Review areas The Healthcare Benefits of Unrelated Donor Haemopoietic Stem Cell Transplantation in the UK The Provision of Stem Cells for Transplantation in the UK Meeting the Demand for Stem Cells in the UK Increasing the Availability of Adult Donor Haemopoietic Stem Cells for Transplantation Increasing the Availability of Cord Blood Units for Transplantation Supply Chain Options for Improving the Availability of Donor Stem Cells in the UK Financial Appraisal of Options to Reconfigure the Supply Chains Health Economic Analysis The Commissioning of Unrelated Donor Stem Cell Transplantation in the UK The Value of Research and Development In Unrelated Donor Stem Cell Transplantation and Regenerative Medicine Performance Managing the Provision of Unrelated Donor Stem Cells for Transplantation Stakeholder Consultation
6 Global Distribution of Hematopoietic Stem Cell Transplantations (HSCTs) in 2006 Gratwohl, A. et al. JAMA 2010;303:
7 Macroeconomic Factors and Transplant Rates UK Transplant Rate per 10m inhabitants Team Density teams per 1m inhabitants Gratwohl, A. et al. JAMA 2010;303:
8 Unrelated donor HSCT trends worldwide.
9 The increasing use of unrelated donor HSCT in older patients
10 The increased use of cord blood in the UK for unrelated donor HSCT in adults
11 Types of stem cell donation transplanted by country and the use of cord blood in unrelated HSCT
12 Worldwide trends in the national and international provision of stem cell donations for HSCT
13 The proportion on stem cells sourced from UK and overseas donors
14 Distribution of ethnic minority individuals in the UK (UK Census data, April 2001) Key: 6.4% to 60.4% 2.5% to 6.3% 1.5% to 2.4% 1.0% to 1.4% 0.2% to 0.9%
15 Patient matching rates by ethnicity (2004/5)
16 Relationship between matching rate and size for large European donor registers
17 OUTCOMES
18
19 Rates and outcome of HSCT according to HDI Giebel S et al, Blood April 2010
20 UD UCBT CENTRE EFFECT DFS BY NUMBER OF TRANSPLANTS PERFORMED 1,0,8,6,4 > 10 transplants: 35 5% at 2 yr,2 P = < 10 transplants: 20 4% at 2 yr 0, Months Eurocord, unpublished.
21
22
23
24
25 Number of transplants Adult HSCT since 2004 UK only SIBLING UNRELATED CORD AUTO Centre
26 Number of transplants Adult Allografts since 2004 UK only in Descending Order TOTAL SIBLING UNRELATED CORD Centre
27 Geographic concentration of adult and paediatric transplant activity in the UK, 2009 ADULT PAEDIATRIC
28 Example of Commissioning Responsibilities Blood and Marrow Transplantation Responsible Party Non-specialised commissioners Specialised commissioners Non-specialised commissioners Pathway Elements All pre-transplant activity up to and including the point of decision to transplant Stem cell harvesting for patients for whom a definite decision to transplant has not been made Autograft Phases 1 to 4 Allograft Phases 0 to 6 and Donor Lymphocyte Infusion if appropriate All subsequent follow up activity following post transplant discharge EXCEPT where a new transplant package of care is instigated Commissioning Currency Routine activity funded at national tariff Locally determined tariffs for the package of care Routine activity funded at national tariff
29 Treatment Phases-Autograft AUTOGRAFT PHASE 1 -Decision to Transplant, Pre Transplant Mobilisation/ Stem Cell Harvest/Manipulation Storage &Pre Transplant Assessment PHASE 2 -Patient Work up inc disease assessment. PHASE 3 -TRANSPLANT ADMISSION / EPISODE - Conditioning regimen/management of Pancytopenic phase and regeneration. PHASE 4 -Discharge to 100 day follow up PHASE day to 1 Year follow up (not included in costing calculations)
30 Treatment Phases-Allograft ALLOGRAFT RELATED/UNRELATED PHASE 1 -Decision to Transplant, patient assessment, Investigations, Donor Matching /Selection / Testing / Tissue Typing PHASE 2 -Patient & Donor Work up PHASE 3 -Donor Harvest including Stem cell manipulation & may include provision of GCSF/ Patient work up etc PHASE 4 -TRANSPLANT ADMISSION Conditioning regimen & Stem cell infusion. Management of pancytopenic phase and Graft vs. Host disease. PHASE 5 -Occasional Requirement for repeat Stem Cell Infusion with / without Chemo if graft failure occurs
31 Treatment Phases-Allograft cont. PHASE 6 - Discharge to 100 day follow up including management of acute - graft versus host disease / infections and other complications PHASE days onwards, Management of Complex Issues; Graft vs. Host disease, secondary Malignancy, opportunistic Infections, excludes Donor Lymphocyte Infusions (not included in costing calculations) PHASE 8 - Donor Lymphocyte Infusions (not included in costing calculations)
32 Associated Tariffs- 2010/11 International Supplement BMT Type Cost model Tariff 10/11 ( ) Antifungal price per transplant Donor Tissue Typing Average cost per transplant Donor Costs Average cost per transplant Total price per transplant Autologous* 29,888 1,631 31,519 Allogeneic related Allogeneic unrelated 46,336 4,622 3, ,914 6,110 3, DLI 7, Example from London consortium with MFF
33 Funding Allocation Phases Autos Allo Related Allo Unrelated 1 17% 22% 3% 2 10% 5% 3% 3 63% 10% 9% 4 10% 48% 70% 5 No Data No Data 6 15% 15% 7 Example: If the charge covers only the period up to discharge then the following should be deducted from the prices in the earlier table, all other things being equal: Phase 4 for Auto (10%) Phase 6 for Allo (15%) Taken from Consortium Costing Model Guidelines Nov 2009
34 Proposed framework for commissioning and performance monitoring the provision of cord blood and adult donor stem cells for HSCT
35 The Findings Each year in the UK, about 170 Caucasian and 90 black and minority ethnic patients fail to locate a suitably matched adult donor. Around 110 patients with a matched donor die or deteriorate beyond transplantation while waiting to be transplanted. Improved access to adult unrelated donors and cord blood donations will cure around an additional 1000 people of an otherwise fatal condition over the next ten years
36 The Recommendations Adult Donors Greater engagement with black and minority ethnic donors Selected donors should be HLA typed to high resolution The UK should introduce predictive search technologies A graft identification advisory service should be established Increase contact with donors
37 The Recommendations Cord Blood The UK should increase its inventory of cord blood to 50,000 high dose units (8,000 currently at NHS-CBB). The inventory should contain 30% to 50% of donations from black and ethnic minority women (40% currently). Newly banked units should contain over 90 x 10 7 TNC (ethnic minority donors) or 120 x 10 7 TNC (Caucasian donors). High resolution HLA typing should be performed on newly stored units and selected existing units.
38 The Recommendations Transplantation Streamline registry activities in the UK Educate commissioners on patient outcomes Cord blood transplantation should be concentrated into designated Centres of Excellence Data collection and outcome monitoring should be integrated into every stage of the patient pathway Designated transplant centres should work together to support an alternative donor clinical trials network A Stem Cell Advisory Forum should build on the work and membership of the UK Stem Cell Strategic Forum
39 The Case for Investment Autumn 2010 Ministerial support for recommendations and a request for NHSBT and Anthony Nolan to develop a joint bid for funding. November business case requests 50.1m over 5 years. Proposal to: a) align NHSBT and Anthony Nolan registry activities b) bank 50,000 cord blood donations over 5 years c) improve provision of adult donors via high res. typing & matching algorithm Separately, NHSBT is: a) implementing operational improvements in BBMR b) implementing EMDIS (July go live) c) HLA DRB1 typing existing cord blood donations
40 Additional Funding of 4m for 2011/12 Ministerial announcement during January 2011 of 4m funding in first instance. NHSBT and Anthony Nolan proposing a collaborative framework which will see: UK transplant centres accessing NHSBT stem cell donors via the Anthony Nolan register Anthony Nolan and NHSBT ramping up cord blood collection and banking to 24/7 Anthony Nolan and NHSBT investing in high resolution typing of selected existing adult donors and cord blood donations pdf
Reference: NHS England B04/P/a
Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation (HSCT) (All Ages): Revised Reference: NHS England B04/P/a 1 NHS England Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation
More informationEUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases
! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center
More informationBlood and Marrow Transplantation Services and QIPP
Blood and Marrow Transplantation Services and QIPP Contents 1. Executive Summary 2. Background 2.1 What is QIPP? 2.2 BMT services the current picture 2.3 QIPP and BMT services 3. Main Themes 3.1 Clinical
More informationHematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine
Hematopoietic Stem Cell Transplantation Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cells Harvested from blood, bone marrow, umbilical cord blood Positive selection of CD34 (+) cells
More informationOUR JOURNEY THROUGH THE YEARS
The King Faisal Specialist Hospital and Research Centre Experience in Hematology, Oncology and Bone Marrow Transplantation OUR JOURNEY THROUGH THE YEARS REGGIE BELKHEDIM A Brief Overview: King Faisal Specialist
More informationUMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE
UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION
More informationPart 1 Findings and Recommendations
The Future of Unrelated Donor Stem Cell Transplantation in the UK Part 1 Findings and Recommendations A Report from the UK Stem Cell Strategic Forum July 2010 www.nhsbt.nhs.uk Foreword Haemopoietic stem
More informationPr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose
Pr Eliane Gluckman, MD, FRCP, Hospital Saint Louis, University Paris- Diderot, France Should Haplo-identical transplantation be preferred to cord blood in patients without a matched donor? Disclosure of
More informationHow To Understand The Science Of Cord Blood
The Future of Unrelated Donor Stem Cell Transplantation in the UK Part 2 Annexes A Report from the UK Stem Cell Strategic Forum July 2010 www.nhsbt.nhs.uk Table of Contents Abbreviations... 6 Glossary...
More informationOutcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP)
Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP) October 18, 2014 19th Congress of APBMT, Hangzhou, China AMIR ALI HAMIDIEH, MD Iranian
More informationBone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris
Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Background Hematopoietic stem cell transplantation (HSCT) is
More informationEquality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants
Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Lown R.N., 1 Marsh S.G.E., 1 Blake H., 1 Evseeva I., 1 MacKinnon, S., 2 Pagliuca,
More informationHow to select a donor and product for allogeneic HCT
How to select a donor and product for allogeneic HCT Dr Bronwen Shaw 10 February 2015 Overview Who (and where) are the donors What factors determine how we choose between them Acquisition Clinical Donor
More informationSEARCHING FOR A BONE MARROW DONOR
SEARCHING FOR A BONE MARROW DONOR Angela received a bone marrow transplant from an unrelated donor to treat her non-hodgkin s lymphoma. INFORMATION FOR PATIENTS AND THEIR FAMILIES For patients who need
More informationInternational NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007
International NetCord Foundation Executive Committee Conference Call Minutes Committee Members: Board Members: Staff: President Joan Garcia and Drs. Yves Beguin and Elizabeth Shpall Drs. Cristina Navarrete
More information5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries
More informationThe donor search: the best donor or cord blood unit
The donor search: the best donor or cord blood unit Dr Bronwen Shaw Consultant in haematopoietic cell transplantation Royal Marsden Hospital /Anthony Nolan Overview Where do we find donors/units for transplantation
More informationPros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa
Pros and Cons of Stem Cell Sources and their availability in Africa Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Introduction The ability to perform a haematopoietic stem
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll
More informationINFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002
INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation
More informationNarrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
More informationUmbilical Cord Blood Transplantation
Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults
More informationCorporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
More informationCorporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
More informationBlood cells are vital to the human body
Candide FONT-SALA Blood cells are vital to the human body Red cells transport oxygen From http://www.english-online.at/biology/blood/blood-supply-and-blood-diseases.htm Red cell life span 120 days 200
More informationUmbilical Cord Blood Stem Cells Current Status & Future Potential
Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu
More informationThe Danish Bone Marrow Donor Registry DBMDR
The DBMDR Vision To achieve and maintain a position as an internationally recognized hematopoietic stem cell donor registry with respect to high quality of donor data base and HLA typing, individualized,
More informationDirected/Related Cord Blood Collection by NHS Blood and Transplant
Directed/Related Cord Blood Collection by Jacqui Thompson Clinical Scientist Section Head of Specialist Procedures Stem Cells and Immunotherapies Department National Blood Service, NHSBT Birmingham Why
More information4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and
More informationUnrelated Donor Stem Cell Transplantation in the UK
Unrelated Donor Stem Cell Transplantation in the UK Effective Affordable Sustainable A Report from the UK Stem Cell Strategy Oversight Committee November 2014 www.nhsbt.nhs.uk Contents Introduction 3
More informationA fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS
A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS Each year, thousands of patients are diagnosed with diseases treatable by a blood stem cell transplant. These blood stem cells can
More informationData Reporting Problems
Data Reporting Problems Shelley Hewerdine & Khrystyna Valkiv Istanbul, 23rd March 2015 #EBMT2015 www.ebmt.org Format of this session Recent EBMT Registry work Improving Data Quality Data reporting Quiz
More informationP R E S S K I T 2013 TABLE OF CONTENTS. About the European Group for Blood and Marrow Transplantation
TABLE OF CONTENTS About the European Group for Blood and Marrow Transplantation Haematopoietic Stem Cell Transplantation (HSCT): Key facts & figures EBMT Data - A foundation for cutting-edge research Clinical
More information10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7
10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in
More informationPublic Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden
HOUSE OF REPRESENTATIVES COMMITTEE ON HEALTH CARE SERVICES ANALYSIS BILL #: HB 2337 (PCB HCS 00-07) RELATING TO: SPONSOR(S): TIED BILL(S): Public Cord Blood Tissue Bank Committee on Health Care Services
More informationOPERATIONS USER GUIDE
OPERATIONS USER GUIDE 1 Ver 1.3 (06/12) CONTENTS 1 Background and organisation of Anthony Nolan 3 2 Patients for whom a search may be requested 5 3 Procedure for requesting HLA testing and a search 6 4
More informationOn April 4, a group of physicians at the 37th annual
By Ronale Tucker Rhodes, MS Better gene sampling and newer transplant regimens are making stem cell transplantation possible for a host of disease states that previously were rarely considered for this
More informationClinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April 2013. Reference: NHSCB/B04/P/a
Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation First published:
More informationA Public Cord Blood Bank for South Africa? i
No. 42/2007 A Public Cord Blood Bank for South Africa? i By Dr Robert Crookes MBChB (Wits), Dip. Internal Medicine (American Board of Internal Medicine, USA) Transfusion Medicine Consultant. South African
More informationLaura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,
Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Lancaster University, UK Today Exploring Perceptions of 'Quality'
More informationDo you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life Sciences @jessbiopharma
1 Who is the most influential figure in cord blood around the world? What is the biggest challenge to overcome in the use of cord blood as a source of stem cells? We asked 10 leading experts in the cord
More informationSAVING LIVES: ACHIEVING MORE
SAVING LIVES: ACHIEVING MORE Anthony Nolan Organisational strategy for 2015-2018 Where we re coming from In 1974, we were the world s first stem cell donor register. And over 40 years later, we re at the
More informationNavelstrengbloed tegen kanker
Navelstrengbloed tegen kanker THERAPIEDAG 2008: "Zorgtrajecten in kanker" Zaterdag 27 september 2008 Gasthuisberg, Leuven. Hélène Schoemans, MD KUL, Stem Cell Institute Leuven Cord blood Collection and
More informationCord Blood Bank Business Plan
Cord Blood Bank Business Plan A sample of how to create a new program Produced by the AABB subsection: Cellular Therapy Business Management with major contributions by Nicole Omer TABLE OF CONTENTS Page
More informationCord blood banking: information for parents
Cord blood banking: information for parents Published August 2006 by the RCOG Contents Page number Key points 1 About this information 2 What is cord blood? 2 Why is cord blood useful? 3 How is cord blood
More informationCord Blood Stem Cell Transplantation
LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral
More informationCPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD
The blood and marrow transplant field has 15 dedicated CPT codes. These CPT codes can be categorized into three groups: 1. Collection Codes 2. Cell Processing Codes 3. Cell Infusion Codes Collection Codes
More informationThe Value of Cord Blood Stem Cells. Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011
The Value of Cord Blood Stem Cells Mona Shafey, MD, FRCPC Medical Grand Rounds October 25 th, 2011 Objectives To discuss umbilical cord blood as a stem cell source and the role of umbilical cord blood
More informationSTEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE
STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE What are Stem Cells? Stem cells are the basic building blocks of all the cells, tissues and organs in the human body. The role of the stem
More informationBone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_epithelial_ovarian_cancer 2/2001 11/2015 11/2016 11/2015 Description
More informationWhat is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
More informationArriving at a better future for people with blood cancer
Arriving at a better future for people with blood cancer CONTENTS Foreword 1 Part One 2 Part Two 4 Statistics 7 Part Three 11 Conclusion 13 Acknowledgements 14 Foreword We re looking ahead to a future
More informationTitle: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION
NZBMDRGuidelines-007.10 Date Effective: 01/05/2010 Page 1 Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION Authorised by: Executive Officer Contributing Authors: ABMDR Scientific Expert
More informationDEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT
www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers
More informationImproving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy
Improving Quality in Cellular Therapy with FACT Accreditation The Foundation for the Accreditation of Cellular Therapy 1 Goals and Services of FACT Promote quality patient care and laboratory practice
More informationBefore your child has a stem cell transplant (SCT)
Before your child has a stem cell transplant (SCT) A guide for families The information contained within this leaflet is the property of Imperial College London Healthcare NHS Trust. Introduction This
More informationSelecting an appropriately matched donor for hematopoietic
Transplant Outcomes in Acute Leukemia (I) Mary Eapen a and John E. Wagner b Umbilical cord blood (UCB) has gradually emerged over the last decade as an alternative source of hematopoietic cells for transplantation
More informationCord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program
Cord Blood: that other stem cell source Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program CBMTG April 2012 The problem: In order to perform a BMT from one person to another one needs
More informationBone Marrow (Stem Cell) Transplant for Sickle Cell Disease
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient
More informationCHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION
CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation
More informationCanadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents
Canadian Blood Services National Public Cord Blood Bank Give Life Twice Transfusion Medicine Residents Eileen Quinlan Collection Supervisor, Brampton (GTA) 2015-11-10 History One Match Stem Cell and Marrow
More informationCellular Therapy and Cord Blood 2013 Market Report
Brochure More information from http://www.researchandmarkets.com/reports/2393891/ Cellular Therapy and Cord Blood 2013 Market Report Description: This is the most up-to-date market report focusing on Cellular
More informationSummary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status
of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Shelley Grant Branch Chief, Blood Stem Cell Transplantation Program September 11, 2015 Overview December 20, 2005 - HRSA began
More informationMilano Cord Blood Bank 18 year report on cord blood banking and transplant
Milano Cord Blood Bank 18 year report on cord blood banking and transplant Paolo Rebulla, MD Milano Cord Blood Bank Center of Transfusion Medicine, Cellular Therapy and Cryobiology Department of Regenerative
More informationH. R. 2107 IN THE HOUSE OF REPRESENTATIVES
I 1TH CONGRESS 1ST SESSION H. R. 2107 To direct the Secretary of Health and Human Services to conduct a public education campaign on umbilical cord blood stem cells, and for other purposes. IN THE HOUSE
More informationDonate your baby s cord blood and save lives.
Donate your baby s cord blood and save lives. A public nonprofit cord blood bank licensed by the FDA Each year, thousands of people are diagnosed with life-threatening diseases that may be cured with a
More informationcord blood 4-1-1230, Off Abids Road, Bogulkunta, Hyderabad 500001. 3-6-282, Opp. Old MLA Qrtrs., Hyderguda, Hyderabad 500029.
Department of Obstetrics cord blood UNIT 1 BOGULKUNTA 4-1-1230, Off Abids Road, Bogulkunta, Hyderabad 500001. UNIT 2 HYDERGUDA 3-6-282, Opp. Old MLA Qrtrs., Hyderguda, Hyderabad 500029. UNIT 3 JUBILEE
More informationThe Anthony Nolan and NHS Stem Cell Registry Annual Review 2014
The Anthony Nolan and NHS Stem Cell Registry Annual Review 2014 1 CONTENTS The very first State of the Registry review showcases the work, achievements and impact of the alignment of all the UK registers
More informationStem Cell Background Paper
Stem Cell Background Paper Introduction...2 Stem Cell Basics...3 Stem Cell Process Flow...9 Comparison of Blood, Stem Cells, Tissues and Organs Processes...10 Responsibilities for the Blood, Stem Cells,
More informationBlood-Forming Stem Cell Transplants
Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic
More informationHelping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.
Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.CA WWW This guide is intended for patients in need of an unrelated volunteer
More informationCellular Therapy and Cord Blood Market Report 2013 Page 1. Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences
Cellular Therapy and Cord Blood Market Report 2013 Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences k.gray@selectbio.com Select Biosciences Market Reports Website: SelectBiosciences.com/marketreports/
More informationCord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD
Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer
More informationCord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape
GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us
More informationNew Zealand Bone Marrow Donor Registry
Title: Authorised by: SECTION 9.0 NZBMDR STANDARDS PROCESS FOR AN UNRELATED STEM CELL DONOR WORKUP & IDENTIFICATION OF CORD BLOOD UNITS Executive Officer Contributing Authors: Sally Gordon Dr Hilary Blacklock
More informationNEWS RELEASE. For Immediate Release. For more information, please contact:
NEWS RELEASE For Immediate Release For more information, please contact: Charlene Han Singapore Cord Blood Bank Tel: (65) 6394-5017 charlene.han.j.j@scbb.com.sg Singapore Cord Blood Bank records 21 st
More informationInfosheet. Allogeneic stem cell transplantation in myeloma. What is the principle behind stem cell transplantation?
Infosheet Allogeneic stem cell transplantation in myeloma High-dose therapy and autologous stem cell transplantation is currently the first-line treatment standard of care for younger/fitter myeloma patients.
More informationGAO NATIONAL CORD BLOOD INVENTORY. Practices for Increasing Availability for Transplants and Related Challenges. Report to Congressional Committees
GAO United States Government Accountability Office Report to Congressional Committees October 2011 NATIONAL CORD BLOOD INVENTORY Practices for Increasing Availability for Transplants and Related Challenges
More informationSAVE A LIFE... BY GIVING LIFE!
SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the
More informationDisclosures. I have no disclosures.
Not Your Own Marrow Jenni Krajewski, MD Clinical Assistant Professor, Rutgers New Jersey Medical School Attending Physician, Pediatric Blood and Marrow Transplantation The Institute for Pediatric Cancer
More informationEconomics of Cord Blood Banking. Michael Boo NMDP Be The Match September 11, 2015
Economics of Cord Blood Banking Michael Boo NMDP Be The Match September 11, 2015 Historical Use UCB Use Data 2 NMDP Historical Transplants by Product 7,000 6,500 6,000 5,500 5,000 4,500 4,000 3,500 3,000
More informationPhone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012-2020
More informationTriennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence
Triennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence August 2015 Title: Triennial Review of NHS Blood and Transplant Call for Evidence Author:
More informationSelection of the Optimal Umbilical Cord Blood Unit
Karen Ballen, MD Selection of the Optimal Umbilical Cord Blood Unit Massachusetts General Hospital September, 2013 OUTLINE Cell Dose HLA Match Allele Level HLA C KIR Directional Mismatch NIMA HLA Antibodies
More informationBone Marrow Transplant Services in New Zealand for Adults
Bone Marrow Transplant Services in New Zealand for Adults Citation: Ministry of Health. 2011. Bone Marrow Transplant Services in New Zealand for Adults Service Improvement Plan. Wellington: Ministry of
More informationStem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD
Stem Cell Transplantation and the Canadian First Nations Community Becky Luk (PTLS) Tanya Petraszko, MD Why is there a need for stem cells? Our Story Why are we engaging the First Nations, Metis and Inuit
More informationGraft Failure After HSCT
Graft Failure After HSCT Vanderson Rocha, MD, PhD Professor of Haematology- Oxford University Bone Marrow Transplant Unit- Sirio Libanes Hospital- Sao Paulo Scientific Director of Eurocord-Paris Clinical
More informationThe Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation
CHAPTER 2 The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation Peggy Appel and Richard T. Maziarz Hematopoietic stem cell transplant (HSCT) is a complex process that is associated
More informationA Cure for Sickle Cell Anemia and Thalassemia
IV Simpósio Internacional de Hemoglobinopatias A Cure for Sickle Cell Anemia and Thalassemia Bertram Lubin, MD and Mark Walters, MD 4 September 2007 Topics to be covered Cord blood: Importance and biology
More informationQ: Why is there a need for people to join the Be The Match Registry?
Q: Why is there a need for people to join the Be The Match Registry? A: Thousands of patients with blood cancers like leukemia and lymphoma, sickle cell and other life-threatening diseases depend on the
More informationHow To Treat Leukaemia With Cord Blood Stem Cell
Cord blood for the treatment of acute lymphoblastic leukemia in young children By Caitlin McGreevy Kiara Paramjothy Pass with Merit RESEARCH PAPER BASED ON PATHOLOGY LECTURES AT MEDLINK 2011 1 Abstract:
More informationMyeloablative versus Reduced Intensity Conditioning Regimen Cord Blood Transplants
Educational 2 Cord Blood Transplantation Myeloablative versus Reduced Intensity Conditioning Regimen Cord Blood Transplants William Arcese University of Rome Tor Vergata Rome Transplant Network 4th April
More informationPediatric Cord Blood Transplantation Webcast August 27, 2008 Colleen Delaney, M.D. M.Sc. Introduction
Pediatric Cord Blood Transplantation Webcast August 27, 2008 Colleen Delaney, M.D. M.Sc Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance,
More informationSTEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA
STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the
More informationWBMT Global Survey. Helen Baldomero Cape Town November 2014. Worldwide Network for Blood and Marrow Transplantation
WBMT Global Survey Helen Baldomero Cape Town November 214 NGO in official relations with World Health Organization Leukemias LPD Solid tumors Non - Malignant disorders NGO in official relations with World
More informationChallenges of Hematopoietic Stem Cell Transplantation. Robert J. Soiffer, MD Dana Farber Cancer Institute
Challenges of Hematopoietic Stem Cell Transplantation Robert J. Soiffer, MD Dana Farber Cancer Institute Hematopoietic Stem Cell Transplantation Objectives Deliver sufficient chemo-radio therapy to destroy
More informationTrasplante de Células Madre Hemopoyéticas. Dos décadas de progreso
Trasplante de Células Madre Hemopoyéticas. Dos décadas de progreso A. Urbano Ispizua Hospital Clinic, Universidad de Barcelona Noviembre de 2011 Al comienzo, estaba la médula ósea Al comienzo, estaba la
More informationUMBILICAL CORD BLOOD HARVESTING & STORAGE
Protocol: TRP009 Effective Date: October 14, 2013 UMBILICAL CORD BLOOD HARVESTING & STORAGE Table of Contents Page COMMERCIAL, MEDICARE & MEDICAID COVERAGE RATIONALE... 1 BACKGROUND... 2 CLINICAL EVIDENCE...
More informationSummary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations
Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations Basic principles are established and the responsibilities of the national government are clarified in
More information